Heart failure (HF) is associated with cognitive impairment. However, we know little about the time course of cognitive change after HF diagnosis, the importance of comorbid atrial fibrillation, or the role of ejection fraction. We sought to determine the associations of incident HF with rates of cognitive decline and whether these differed by atrial fibrillation status or reduced versus preserved ejection fraction.
H
eart failure (HF) is a common chronic condition in older adults and is associated with cognitive impairment and dementia, [1] [2] [3] which lead to difficulties in self-care and higher risks for hospitalization and mortality. [4] [5] [6] [7] Our understanding of the time course of cognitive change in HF is limited because most prior longitudinal studies of cognitive decline in HF were based on small groups of participants with HF, had <1 year of follow-up, lacked non-HF comparison groups, or had inadequate adjustment for vascular risk factors. 8, 9 A few longitudinal studies with follow-up beyond 1 year and non-HF comparison groups provide some evidence that HF is associated with faster cognitive decline. [10] [11] [12] [13] However, those studies, too, were limited by including relatively small groups of participants, combining people who had a history of HF at baseline with those who had incident HF diagnosed during follow-up without accounting for time elapsed since HF diagnosis, or grouping together cognitive test scores obtained before and after incident HF diagnosis to estimate cognitive trajectories. Therefore, there is a need for results from larger long-term studies of participants with incident HF, with statistical modeling that differentiates between cognitive test scores obtained before versus after HF diagnosis, to estimate how quickly cognition declines after incident HF diagnosis.
HF often manifests with concomitant atrial fibrillation (AF). In a previous analysis, we showed that incident AF was associated with faster cognitive decline in older adults.
14 Would HF and AF interact synergistically in relation to long-term cognitive decline? Data to address this question are sparse. In several cross-sectional studies of people with HF, those with concomitant AF had higher odds of cognitive impairment than those without AF. 15 However, prior longitudinal studies did not assess whether long-term cognitive trajectories in HF differed according to AF status.
Another gap in our understanding of HF and longterm cognitive decline relates to left ventricular ejection fraction (EF). Would HF with reduced EF have a stronger relationship with cognitive decline than HF with preserved EF? Data to address this issue are limited. Cross-sectional data suggest that cognitive performance in people with HF varies according to whether EF is reduced or preserved. 16, 17 However, prior longitudinal studies did not compare long-term cognitive trajectories in people with HF who had reduced versus preserved EF.
To address these knowledge gaps, we sought to determine associations of incident HF and duration of HF with long-term cognitive trajectories and whether these associations differed by presence versus absence of AF or by reduced versus preserved EF. We used cognitive measures obtained longitudinally in a large community-based cohort of older adults in which newly diagnosed HF was identified during follow-up, and statistical models that differentiated between cognitive test scores obtained before and after incident HF diagnosis. Our goal was to produce estimates of average cognitive trajectories after incident HF diagnosis, which would allow people with newly diagnosed HF, their families, and clinicians to anticipate the average rate at which cognitive decline may occur.
METHODS

Design, Setting, and Participants
The CHS (Cardiovascular Health Study)-a community-based longitudinal study-was conducted to identify risk factors for and consequences of cardiovascular diseases in older adults. 18 CHS included 5888 men and women aged ≥65 years enrolled in 1989/1990 and 1992/1993 in Sacramento County, CA; Washington County, MD; Forsyth County, NC; and Allegheny County, PA. For this analysis, participants were followed through 1998/1999. Prevalent cardiovascular disease and risk factors were ascertained at enrollment. 19 Updated risk factor data and functional measures, including cognitive performance, were collected at annual clinic visits through 1998/1999. Incident cardiovascular events were ascertained throughout follow-up and adjudicated according to standard criteria. 20, 21 Participants were included in this analysis if they did not have prevalent HF at enrollment, had at least 1 cognitive assessment obtained at enrollment or during follow-up, and had complete covariate data ( Figure  I in the Data Supplement). Participants who had a history of clinical stroke at enrollment were excluded, and participants were censored at occurrence of incident clinical stroke because stroke is known to be associated with more rapid
WHAT IS NEW?
• Global cognitive ability declined significantly faster after newly diagnosed (incident) heart failure (HF) relative to no history of HF, in the absence of clinical stroke.
• The faster rate of decline after incident HF was evident across all ages between 70 and 90 years and was significantly more pronounced at older ages.
• The association of incident HF with more rapid cognitive decline did not differ significantly by whether participants had concomitant atrial fibrillation.
• The rate of cognitive decline after incident HF did not differ significantly by whether ejection fraction was reduced or preserved.
WHAT ARE THE CLINICAL IMPLICATIONS?
• Clinicians may use our estimates of cognitive trajectories to anticipate average rates of cognitive decline that may occur in their populations of patients who have newly diagnosed HF.
cognitive decline, and therefore, we wanted to focus on cognitive trajectories in people free of clinical stroke. Institutional Review Boards at the coordinating center at the University of Washington and each field center approved the study, and participants gave written informed consent. The Institutional Review Board at Brigham Young University approved the use of these data for this analysis. Requests to access the data set from qualified researchers trained in human subjects confidentiality protocols may be sent to the Collaborative Health Studies Coordinating Center (https://www.uwchscc.org) at the University of Washington, Seattle, WA.
Assessment of HF and EF
History of HF before enrollment was identified by participant report and verified by medical record review. 19 During followup, hospitalizations were identified by participant report and discharge diagnoses from Medicare data. 20 Following these reports, incident HF was identified and confirmed by review of outpatient or inpatient medical records and diagnostic tests. [20] [21] [22] [23] The CHS Events Committee adjudicated incident HF on the basis of appropriate symptoms and signs of HF in the medical record, pulmonary edema on chest radiograph or other supporting clinical findings, or medication prescribed for HF. [20] [21] [22] [23] After a confirmed incident HF diagnosis, a participant was considered to have HF throughout the remainder of follow-up for this analysis.
Approximately 50% of participants who developed incident HF had left ventricular EF data at the time of HF diagnosis available from medical record review ( Figure I in the Data Supplement), derived from echocardiography, cardiac catheterization, multigated acquisition scanning, or other modalities. For this analysis, we classified EF <45% as reduced EF, and EF ≥45% as preserved EF. We did not include EF data in this analysis for participants who did not develop incident HF.
Assessment of AF
AF was identified by electrocardiograms obtained at annual clinic visits and hospital discharge diagnosis codes. 19, 24, 25 
Assessment of Cognitive Function
Global cognitive function was assessed longitudinally using the 100-point Modified Mini-Mental State Examination (3MSE). 26 The 3MSE was administered annually, up to 9x per participant from 1990/1991 through 1998/1999. The 3MSE includes questions assessing memory, orientation, fluency, problem solving, and ability to follow instructions, yielding a global cognitive score between zero (worst) and 100 (best). During 1995/1996 to 1998/1999, for participants not able to complete an in-person examination, telephone-based measures of global cognitive performance were obtained, including the Telephone Interview for Cognitive Status and the Informant Questionnaire on Cognitive Decline in the Elderly. 27, 28 These were used to estimate the missing 3MSE scores using equations previously developed for CHS data ( Figure I in the Data Supplement). 29 Processing speed was assessed longitudinally using the Digit Symbol Substitution Test (DSST). 30 The DSST was administered annually, up to 10× per participant from 1989/1990 through 1989/1999. The DSST consists of a visual motor task in which, for 90 seconds, a person matches symbols with correct digits according to a key, yielding a measure of information processing speed on a scale of zero (worst) to 90 (best).
Assessment of Other Variables
Age, birth year, sex, race, years of education, and use of cigarettes and alcohol were determined by participant report. Medication use was determined by annual medication inventory. 31 Creatinine, hemoglobin, and glucose were measured in blood samples. 32 Blood pressure was recorded as the average of 2 measurements. Body mass index was calculated from measured height and weight. Chronic obstructive pulmonary disease was identified by participant report. Chronic kidney disease was defined as estimated glomerular filtration rate <60 mL/min per 1.73 m 2 based on serum creatinine and the Chronic Kidney Disease Epidemiology Collaboration equation. 33 Anemia was defined as hemoglobin <13 g/dL for men and <12 g/dL for women. 34 Stroke and coronary heart disease were identified by participant report or proxy report, confirmed by medical record review and adjudicated according to standard criteria. [19] [20] [21] 35 Diabetes mellitus was defined as the use of insulin or oral hypoglycemic medications or fasting serum glucose ≥126 mg/dL or nonfasting serum glucose ≥200 mg/dL. Hypertension was defined as self-reported physician-diagnosed hypertension plus use of antihypertensive medication or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. Stroke, coronary heart disease, AF, diabetes mellitus, and hypertension status were initially defined at enrollment and then updated during follow-up. A participant was considered to have diabetes mellitus through the end of follow-up after the first observed elevated glucose or reported use of antidiabetic medication. All other covariates were defined at enrollment and considered non-time-varying.
Statistical Analysis
We developed statistical models separately for each cognitive function test (3MSE and DSST). We used linear mixed models with age as the time scale to model the relationship of incident HF with longitudinal cognitive trajectory. 36 Incident HF was a time-varying variable, coded as absent (zero) at the beginning of follow-up for all participants, and then recoded to present (1) part of the way through follow-up at the age of HF diagnosis for participants who experienced incident HF. We considered intercept, age, and age-squared to be random at the participant level and included them as random effects with a spatial exponential covariance structure. We included incident HF and time elapsed since incident HF diagnosis as time-varying fixed effects; and the following 4 multiplicative interaction terms of HF variables with age variables as fixed effects: incident HF×age, incident HF×age-squared, time elapsed since incident HF diagnosis×age, and time elapsed since incident HF diagnosis×age-squared. Thus, average cognitive performance with no history of HF at any given age was based on cognitive test scores obtained from participants with no history of HF at that age, including those participants who went on to experience incident HF at older ages ( Figure I in the Data Supplement). We also included other variables listed above as fixed effects to adjust for potential confounding. To determine whether the cognitive trajectory across age differed significantly by incident HF, we used an F test to simultaneously test the 4 interaction terms, thereby comparing our primary model as specified above with a simpler model that did not include interactions of HF variables with age variables. We graphed model-predicted cognitive trajectories according to age and HF status and calculated model-predicted 5-year declines in cognitive performance without HF and after incident HF diagnosis.
To explore whether the association of incident HF with cognitive decline differed according to presence versus absence of AF, we augmented the models described above with multiplicative interaction terms for AF with incident HF and age variables as fixed effects, including four 2-way interaction terms: AF×incident HF, AF×time elapsed since incident HF diagnosis, AF×age, and AF×age-squared; and four 3-way interaction terms: AF×incident HF×age, AF×incident HF×age-squared, AF×time elapsed since incident HF diagnosis×age, and AF×time elapsed since incident HF diagnosis×age-squared. We used 2 different F tests to assess this model. First, to determine whether cognitive trajectories estimated from our primary model differed overall by AF status, we simultaneously tested all 8 interaction terms involving AF, thereby comparing this model with our primary model. Second, to determine whether the differences in cognitive trajectory across age by incident HF further differed significantly by AF status, we simultaneously tested the four 3-way interaction terms involving AF, HF, and age variables, thereby comparing this model with an intermediate model that included only 2-way interactions of AF with HF and age variables but no 3-way interactions. We graphed model-predicted cognitive trajectories and calculated model-predicted 5-year declines in cognitive performance, similar to the primary analysis but stratified by AF status.
To explore the association of EF with rate of cognitive decline after HF diagnosis, we classified each participant with HF as having reduced EF, preserved EF, or unknown EF. For these models, we included only post-HF cognitive test scores; used time since incident HF diagnosis as the time scale instead of age; included intercept and time as random effects; included EF category and EF category×time as fixed effects; and adjusted for age at incident HF diagnosis, sex, race, and education as fixed effects. We considered a time-squared term but omitted it because it did not significantly improve the estimate of average cognitive test score trajectory over time; a linear term for time since incident HF diagnosis was sufficient. Using this simpler model, we estimated model-predicted 5-year declines in cognitive performance after incident HF diagnosis for each EF category.
In a sensitivity analysis, we omitted participants who had only 1 cognitive assessment and analyzed only participants who had multiple cognitive assessments over time. In another sensitivity analysis, we omitted 3MSE scores estimated from telephone-based cognitive assessments and analyzed only directly measured 3MSE scores.
Statistical analyses were conducted in SAS, version 9.4 (SAS Institute, Cary, NC), and R, version 3.2.4 (R Development Core Team, www.r-project.org). Dr Thacker had full access to all the data in the study and took responsibility for its integrity and the data analysis.
RESULTS
Incident HF and Participant Characteristics
Incident HF was identified in 496 (10.2%) of 4864 participants during a mean of 6.4 years of follow-up (maximum of 8 years) in 3MSE analyses and in 389 (7.8%) of 4969 participants during a mean of 6.5 years of follow-up (maximum of 9 years) in DSST analyses. A greater number of incident HF cases were identified in 3MSE analyses than for DSST analyses because follow-up for 3MSE analyses was extended into older ages for some participants by estimating missing 3MSE scores using telephone-based cognitive measures (see above and Figure I in the Data Supplement). Participants who developed incident HF were on average older, more often men, of white race, and at higher cardiovascular risk than those who did not develop incident HF (Table 1; Table I in the Data Supplement).
Modified Mini-Mental State Examination
We analyzed 34 854 3MSE scores obtained from 4864 participants, representing >90% of potential 3MSE scores that could have been obtained had there been no censoring and no missed exams. A summary of 3MSE scores not obtained or not analyzed because of censoring or missed exams is given in Figure I in the Data Supplement. Model-predicted trajectories of mean 3MSE score are illustrated in Figure 1A . With no history of HF (solid curve), mean 3MSE declined steeply after 75 years of age. Model-predicted trajectories of mean 3MSE score after incident HF diagnosed at ages 70, 75, 80, and 85 are shown in 4 dashed curves. Mean 3MSE score declined faster after incident HF diagnosis relative to no history of HF. For example, decline in mean 3MSE score from 80 to 85 years of age was 10.2 points (95% confidence interval, 8.6-11.8) after incident HF diagnosed at 80 years of age, compared with mean decline of 5.8 points (95% confidence interval, 5.3-6.2) from 80 to 85 years of age without HF (Table 2) . We observed age-related differences in the association of incident HF with mean 3MSE score: older age at HF diagnosis was associated with larger differences in trajectories of mean 3MSE score after HF diagnosis relative to no history of HF. Model coefficients and standard errors are in Table II in the Data Supplement.
Digit Symbol Substitution Test
We analyzed 34 769 DSST scores obtained from 4969 participants, representing >84% of potential DSST scores that could have been obtained had there been no censoring and no missed exams. A summary of DSST scores not obtained or not analyzed because of censoring or missed exams is given in Figure I in the Data Supplement. Model-predicted trajectories of mean DSST score are illustrated in Figure 1B . Rate of decline in mean DSST score with advancing age was not significantly different after incident HF relative to no history of HF. For example, decline in mean DSST score from 80 to 85 years of age was 6.1 points (95% confidence interval, 4.4-7.8) after incident HF diagnosed at age 80 years of age, compared with mean decline of 4.7 points (95% confidence interval, 4.4-5.0) from 80 to 85 years of age without HF (Table 3 )-a statistically nonsignificant difference. We did not observe age-related differences in the association of incident HF with mean DSST score; differences in trajectories of mean DSST score after HF diagnosis relative to no history of HF were similar across the age range. Model coefficients and standard errors are in Table II in the Data Supplement.
Interaction of AF With Incident HF
Model-predicted trajectories of mean 3MSE score in the presence or absence of AF are shown in Figure 2A and 2B. Overall, 3MSE trajectories were significantly different in the presence of AF versus absence of AF (P=0.027); this overall difference was explained by mean modelpredicted 3MSE score declining more quickly with age in the presence of AF than in its absence, regardless of incident HF, especially at older ages (Figure 2A) . However, the magnitude of accelerated decline in 3MSE score after incident HF diagnosis was not significantly different in the presence versus absence of AF (P=0.084; for magnitudes of these differences, see Table 4 ). Overall trajectories of DSST score were not significantly different by AF status (P=0.339), nor were differences in decline in DSST score by incident HF significantly different by AF status (P=0.505; Figure 2C and 2D; Table 4 ).
HF With Reduced, Preserved, or Unknown EF
After HF diagnosis, rates of cognitive decline by EF category were not significantly different ( Table 5 ). Precision of these estimates was poor because of relatively sparse data within each EF category.
Sensitivity Analyses
Results were similar when we omitted participants who had only 1 cognitive assessment or when we omitted 3MSE scores estimated from telephone-based cognitive assessments.
DISCUSSION
In this longitudinal study of older adults, participants who developed incident HF experienced faster †All percentages in the table are column percentages. Mean drinks per week was calculated among participants who reported any current alcohol use. For diabetes mellitus, hypertension, coronary heart disease, and AF, percentages of participants with the condition present at enrollment and of those with the incident condition occurring during follow-up were mutually exclusive and, therefore, sum to the total percentage of participants with the condition either present at enrollment or occurring during follow-up (mean of 6.4 y). Incident diabetes mellitus, hypertension, coronary heart disease, or AF may have occurred before or after incident HF diagnosis. average decline in global cognitive ability than their peers of the same age who had no history of HF. Differences between the rates of decline in 3MSE score after incident HF diagnosis versus with no history of HF were larger at older ages than at younger ages. We are unable to conclude that there is an association of incident HF with decline in psychomotor processing speed. The association of incident HF with decline in DSST score was smaller in magnitude than the association with decline in 3MSE score, fell short of statistical significance, and did not vary significantly by age.
Four previous studies with follow-up >1 year compared cognitive trajectories in adults with versus without HF (Table III in the Data Supplement). 10-13 Their results did not support a consistent profile of cognitive deficits in people with HF but rather suggested that an association of HF with cognitive decline can be detected by some neuropsychological tests when a variety of tests are used. Our study agreed with 1 prior study 12 in finding a statistically significant association of HF with faster decline in global cognitive ability and with 3 prior studies [10] [11] [12] in finding that the association of HF with rate of decline in processing speed (DSST) was small in magnitude and not statistically significant.
Our study has several methodologic strengths. First, we excluded participants who had prevalent HF at study †Adjusted for birth year, sex, race, education, cigarette smoking, alcohol use, β-blocker use, angiotensin-converting enzyme inhibitor use, systolic blood pressure, body mass index, chronic kidney disease, chronic obstructive pulmonary disease, anemia, diabetes mellitus, hypertension, coronary heart disease, and AF. Participants were censored at the development of clinically recognized stroke. enrollment, modeled cognitive trajectories after incident HF diagnosis, and used time-varying variables for incident HF and time elapsed since incident HF. Second, we excluded participants who had a history of clinically recognized stroke, and censored participants when they developed clinical stroke, allowing us to rule out the possibility that accelerated cognitive decline after HF diagnosis is explained merely by a higher rate of clinical stroke. Third, we used interaction terms between age and HF variables in our statistical models, enabling us to observe that the association of incident HF with 3MSE trajectory differed by age. Fourth, we conducted a large study with long follow-up, allowing us to graph model-predicted trajectories with excellent precision.
In our previously published work on AF and cognitive decline, 14 our model predicted that people diagnosed with incident AF at 80 years of age would experience on average a 9-to 12-point decline in 3MSE score during the next 5 years, whereas people the same age without AF would experience only a 6-to 7-point decline during 5 years. Similarly, in this new analysis, we observed that people diagnosed with incident HF at 80 years of age would be expected to show on average a 9-to 12-point decline during 5 years, compared with an average 5-to 6-point decline without HF. To build on this understanding that both AF and HF are independently associated with cognitive decline, in the present work, we took a further step, using more complex models to assess whether AF and HF would interact synergistically to hasten cognitive decline. For 3MSE, when we assessed the possibility of an interaction of AF with incident HF, we found that average cognitive performance declined faster, overall, in the presence of AF, as we would expect from our prior work.
14 However, we did not see evidence of synergism between AF and HF; rather, we observed that the magnitude of the association of incident HF with rate of cognitive decline was not significantly different in the presence versus absence of AF. Our results are congruent with previously published cross-sectional data showing that patients with HF who also had AF were more likely to be cognitively impaired, 15 but this observation may be explained by independent effects of AF and HF, rather than by an interaction of AF with HF.
We observed similar degrees of cognitive decline after HF diagnosis among participants with reduced EF, those with preserved EF, and those with unknown EF. Although we hypothesized that reduced EF would be associated with faster cognitive decline than preserved EF on the basis of previously published research, 16 ,17 our results did not support this hypothesis. Unfortunately, we lacked precision to detect significant differences in rates of cognitive decline after incident HF diagnosis by EF category. Therefore, answering this question will require further investigation in other settings.
Our study has limitations. First, we did not have tests of specific cognitive domains other than psychomotor processing speed. Second, we had low statistical power to investigate whether EF category was associated with different cognitive trajectories. Third, our results may have been influenced by nonrandom loss to follow-up ( Figure I in the Data Supplement). Individuals who have cognitive impairment or HF are more likely to miss cognitive assessments than those who are cognitively intact and free of HF, leading to underestimated average rates of cognitive decline. 37 Fourth, shared risk factors for HF and cognitive decline, such as genetics, patterns of physical activity or diet, and severity or duration of diabetes mellitus and hypertension, may have confounded the association of HF with cognitive change, even in our adjusted models. Fifth, our data were collected in the 1990s and are, therefore, ≥20 years old. However, the high-quality study design, community-based sample, data collection, length of follow-up, and statistical analysis make these data ideal for studying the epidemiology of incident HF and long-term cognitive decline.
It is biologically plausible that HF could cause cognitive decline. Neuroimaging studies suggest that many brain regions involved in cognition sustain injury in HF. 38 Commonly cited mechanisms by which HF is thought to reduce cognitive ability are cerebral hypoperfusion and cerebral microemboli. 4 ,5,39 How- †Adjusted for birth year, sex, race, education, cigarette smoking, alcohol use, β-blocker use, angiotensin-converting enzyme inhibitor use, systolic blood pressure, body mass index, chronic kidney disease, chronic obstructive pulmonary disease, anemia, diabetes mellitus, hypertension, coronary heart disease, and AF. Participants were censored at the development of clinically recognized stroke.
ever, those explanations may not be sufficient. Subclinical left ventricular dysfunction is associated with neuropsychological dysfunction and subclinical vascular brain injury, suggesting relatively subtle mechanisms. [40] [41] [42] Additional mechanisms could include systemic inflammation, oxidative damage, homocysteinemia, elevated B-type natriuretic peptide, thiamine deficiency, neurohormonal dysfunction, altered cellular metabolism, and impaired cerebrovascular reactivity. 1, 5, 38, [43] [44] [45] [46] Alternatively, HF may be a marker of underlying nonspecific influences on cognitive ability, such as poor general health, overall burden of illness, hospitalization, multimorbidity, polypharmacy, or fatigue. Based on our results, older adults who were diagnosed with HF were more likely than their peers with no history of HF to show global cognitive deficits or processing speed deficits, even when HF was first diagnosed. People with HF then experienced, on average, more rapid subsequent decline in global cognitive performance than people who had no history of HF. This association was not significantly different by AF status or by EF category. It remains to be seen whether early and consistent optimal HF management can counteract or prevent associated decline in cognitive function in people with HF. This research was supported by contracts HHSN  268201200036C, HHSN268200800007C, N01HC55222,  N01HC85079, N01HC85080, N01HC85081, N01HC85082,  N01HC85083, N01HC85086, N01HC85084, and N01HC35129 and grants U01HL080295 and U01HL130114 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke. 3MSE indicates Modified Mini-Mental State Examination; AF, atrial fibrillation; DSST, Digit Symbol Substitution Test; and HF, heart failure. *Adjusted for birth year, sex, race, education, cigarette smoking, alcohol use, β-blocker use, angiotensin-converting enzyme inhibitor use, systolic blood pressure, body mass index, chronic kidney disease, chronic obstructive pulmonary disease, anemia, diabetes mellitus, hypertension, and coronary heart disease.
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